Med Business World

Your source for healthcare business

Colin W. Howden

RedHill Announces FDA sNDA Approval for Talicia®

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced the U.S. Food and Drug Administration’s (FDA) approval of its supplemental new drug application (sNDA) for Talicia[3], allowing a change to a more flexible three times…